Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Plaque-type Psoriasis”

85 trials

Showing 20 of 85 results

Not applicableStudy completedNCT00800982
What this trial is testing

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

Who this might be right for
Psoriasis
University of California, San Francisco 30
Testing effectiveness (Phase 2)Study completedNCT01490632
What this trial is testing

A Phase 2b Study of Baricitinib in Participants With Moderate to Severe Psoriasis

Who this might be right for
PsoriasisSkin DiseasesSkin Diseases, Papulosquamous
Eli Lilly and Company 271
Testing effectiveness (Phase 2)Study completedNCT02209753
What this trial is testing

BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis

Who this might be right for
Psoriasis
Boehringer Ingelheim 182
Large-scale testing (Phase 3)Study completedNCT03047395
What this trial is testing

Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

Who this might be right for
Psoriasis
AbbVie 2,170
Testing effectiveness (Phase 2)Study completedNCT01154101
What this trial is testing

Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Sirtris, a GSK Company 40
Testing effectiveness (Phase 2)Study completedNCT03000075
What this trial is testing

BI 655066 (Risankizumab) Compared to Placebo in Japanese Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 182
Large-scale testing (Phase 3)Study completedNCT02905331
What this trial is testing

Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Moderate to Severe Plaque-Type Psoriasis

Who this might be right for
Psoriasis
Janssen Research & Development, LLC 78
Large-scale testing (Phase 3)Study completedNCT01313221
What this trial is testing

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 310
Testing effectiveness (Phase 2)Study completedNCT01988103
What this trial is testing

Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis

Who this might be right for
PsoriasisPsoriatic ArthritisPsoriasis Arthropatica
Amgen 254
Large-scale testing (Phase 3)Study completedNCT00267969
What this trial is testing

Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 766
Large-scale testing (Phase 3)Study completedNCT02474069
What this trial is testing

Secukinumab Dosage Optimisation in Partial Responders With Moderate to Severe Plaque-type Psoriasis

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 772
Large-scale testing (Phase 3)WithdrawnNCT01936688
What this trial is testing

Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)

Who this might be right for
Plaque-type Psoriasis
Sun Pharmaceutical Industries Limited
Large-scale testing (Phase 3)Study completedNCT03668613
What this trial is testing

Study to Assess the Long-term Safety, Tolerability, Efficacy of Secukinumab in Pediatric Patients of Age 6 to <18 Years, With Moderate to Severe Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque-type Psoriasis
Novartis Pharmaceuticals 84
Large-scale testing (Phase 3)Ended earlyNCT01163253
What this trial is testing

A Long Term Study To Evaluate The Safety And Tolerability Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 2,867
Large-scale testing (Phase 3)Study completedNCT02394561
What this trial is testing

A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)

Who this might be right for
Plaque Type Psorisis
Novartis Pharmaceuticals 434
Large-scale testing (Phase 3)Study completedNCT00307437
What this trial is testing

The Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis

Who this might be right for
Psoriasis
Centocor Research & Development, Inc. 1,230
Large-scale testing (Phase 3)Study completedNCT01555125
What this trial is testing

First Study of Secukinumab in Pre-filled Syringes in Subjects With Chronic Plaque-type Psoriasis: Response at 12 Weeks

Who this might be right for
Moderate to Severe Plaque-type Psoriasis
Novartis Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01519089
What this trial is testing

A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis

Who this might be right for
Psoriasis
Pfizer 95
Testing effectiveness (Phase 2)Study completedNCT00669916
What this trial is testing

A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 36
Testing effectiveness (Phase 2)Study completedNCT04207801
What this trial is testing

A Phase II Study to Evaluate Efficacy & Safety of AUR101 in Patients of Moderate-to-Severe Psoriasis

Who this might be right for
Chronic Plaque-type Psoriasis
Aurigene Discovery Technologies Limited 90
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation